[Skip to Navigation]
Comment & Response
June 2017

Prognosis Using Planar Imaging in Cardiac Amyloidosis—Reply

Author Affiliations
  • 1The Center for Advanced Cardiac Care, Columbia University Medical Center, New York, New York
  • 2Nuclear Cardiology Laboratory, Division of Cardiology, Department of Medicine, Columbia University Medical Center, New York, New York
JAMA Cardiol. 2017;2(6):704-705. doi:10.1001/jamacardio.2016.5888

In Reply Sperry et al raise important discussion points pertaining to our multicenter study of technetium Tc 99m pyrophosphate cardiac imaging for diagnosis and prognosis of cardiac transthyretin amyloidosis (ATTR).1 Our colleagues note that bone abnormalities in the ribs of elderly patients with osteoporosis may pose a technical complication in the calculation of the heart-to-contralateral (H/CL) ratio when using planar imaging. Indeed, it is not uncommon to encounter bony pathology, such as osteoporotic rib fractures or metastatic bone lesions, in planar imaging of the chest. In our practice, when such hot spots are encountered, we avoid them by adjusting the size and location of the circular region of interest. As long as the regions of interest drawn over the heart and contralateral chest remain equal in size and within the chest cavity for each individual patient, bony pathology can usually be avoided, protecting the integrity of the H/CL ratio.

Add or change institution